Snipr Biome - A Crispr Company

Snipr Biome - A Crispr Company company information, Employees & Contact Information

We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.

Company Details

Employees
41
Founded
-
Address
Lersø Parkallé, Copenhagen,capital Region,denmark
Email
co****@****ome.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Copenhagen, Capital Region
Looking for a particular Snipr Biome - A Crispr Company employee's phone or email?

Snipr Biome - A Crispr Company Questions

News

SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance - SynBioBeta

SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance SynBioBeta

Danish BioTech scale-up SNIPR Biome raises €35 million to target antimicrobial resistance in diseases like cancer - EU-Startups

Danish BioTech scale-up SNIPR Biome raises €35 million to target antimicrobial resistance in diseases like cancer EU-Startups

Danish biotech company grabs €35 million Series B to develop CRISPR therapies for infections and resistance - ArcticStartup

Danish biotech company grabs €35 million Series B to develop CRISPR therapies for infections and resistance ArcticStartup

SNIPR Biome Secures €35M Series B for CRISPR Therapies - StartupHub.ai

SNIPR Biome Secures €35M Series B for CRISPR Therapies StartupHub.ai

Snipr Biome raises EUR millions despite a “difficult market” - medwatch.com

Snipr Biome raises EUR millions despite a “difficult market” medwatch.com

SNIPR Biome Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes - GlobeNewswire

SNIPR Biome Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes GlobeNewswire

SNIPR BIOME expands its Executive Management team and opens offices in the US and UK - Cision News

SNIPR BIOME expands its Executive Management team and opens offices in the US and UK Cision News

SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark - SynBioBeta

SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark SynBioBeta

SNIPR Biome sees positive results for first-in-human CRISPR microbial gene therapy - Labiotech.eu

SNIPR Biome sees positive results for first-in-human CRISPR microbial gene therapy Labiotech.eu

SNIPR BIOME commences dosing in Phase I trial of CRISPR-based therapy - Clinical Trials Arena

SNIPR BIOME commences dosing in Phase I trial of CRISPR-based therapy Clinical Trials Arena

MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR microbiome therapeutics - MD Anderson Cancer Center

MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR microbiome therapeutics MD Anderson Cancer Center

Clinical Update: SNIPR Biome Reports Positive Phase 1 Results For CRISPR-Armed Phage Therapy - CRISPR Medicine News

Clinical Update: SNIPR Biome Reports Positive Phase 1 Results For CRISPR-Armed Phage Therapy CRISPR Medicine News

SNIPR Biome Reports Good Initial "In-Human" Results for CRISPR Gene Therapy - Inside Precision Medicine

SNIPR Biome Reports Good Initial "In-Human" Results for CRISPR Gene Therapy Inside Precision Medicine

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice - Nature

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice Nature

SNIPR Biome receives funding from CARB-X to support - GlobeNewswire

SNIPR Biome receives funding from CARB-X to support GlobeNewswire

SNIPR Biome Receives CARB-X Funding to Test SNIPR001 in Phase 1B/2A Clinical Trial - CRISPR Medicine News

SNIPR Biome Receives CARB-X Funding to Test SNIPR001 in Phase 1B/2A Clinical Trial CRISPR Medicine News

Clinical Update: SNIPR Biome Doses First Human Subjects With CRISPR-Based Antibiotic - CRISPR Medicine News

Clinical Update: SNIPR Biome Doses First Human Subjects With CRISPR-Based Antibiotic CRISPR Medicine News

First cancer patient dosed in CRISPR-armed phage therapy - CRISPR Medicine News

First cancer patient dosed in CRISPR-armed phage therapy CRISPR Medicine News

Turning CRISPR into a bacteria killer. A new principle in antibiotics. Interview: Christian Grøndahl, CEO SNIPR BIOME: - CRISPR Medicine News

Turning CRISPR into a bacteria killer. A new principle in antibiotics. Interview: Christian Grøndahl, CEO SNIPR BIOME: CRISPR Medicine News

Win-win or naivete? – Snipr Biome to spill its secrets - medwatch.com

Win-win or naivete? – Snipr Biome to spill its secrets medwatch.com

AMR: Snipr Biome Aps raises €43m to programme pathogens for death - European Biotechnology Magazine

AMR: Snipr Biome Aps raises €43m to programme pathogens for death European Biotechnology Magazine

Top Snipr Biome - A Crispr Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant